Dr. Sharman's CLL & Lymphoma Blog

Translating basic science and clinical breakthroughs into language we all can understand

Pages

  • Home
  • CLL Topics
  • NHL Topics
  • Research
  • CLL / NHL Doctors
  • WVCI Open Studies

CLL Topics


CLL Biology Topics
growth kinetics
clonal diversity
clonal diversity - part 2
Stereotyped receptors and prognosis
Mutated and Unmutated CLL (IgVH hypermutation)

Clinical Management
Understanding FISH testing
13q
11q
17p
Trisomy 12
Prognosis
Defining the new markers in CLL that determine prognosis
When to treat CLL
Watch and Wait
Richter's Syndrome
CT scans and PET scans
Monoclonal B Cell Lymphocytosis (MBL)


Treatment
Choosing first line treatment 2013 version
Choosing a treatment 2016 version
FCR
FCR versus BR
Avoiding Chemotherapy
B-Cell Receptor
BCL-2
CD20 Antibodies
Tumor Lysis Syndrome
"Engineered T-Cells"
Research Drugs Update 2013
Nutritional Supplements
Finding a clinical trial
Stem Cell Transplant
Off label drug use


Other
Dying
How did I get CLL
Telling your story



Home
View mobile version
Subscribe to: Posts (Atom)
Twitter @Jeff_Sharman

Willamette Valley Cancer

Willamette Valley Cancer
I am a hematologist oncologist practicing at the Willamette Valley Cancer Institute in Eugene Oregon. I am also the medical director of hematology research for US Oncology a community based research network with sites throughout the United States.

The purpose of this blog is to serve as a resource for the patients I see every day. In our visits, I often find I want to give a more comprehensive discussion than what time allows. I hope this blog allows my patients to feel more informed about what we are doing and why we are recommending it.

This blog is NOT a substitute for medical advice from your own doctor and should not be interpreted as an individual therapeutic recommendation

Total Pageviews

Search This Blog

Translate

Posts By Topic

  • 11q (2)
  • 13q (3)
  • 17p (7)
  • Antibody Drug Conjugate (2)
  • atm (2)
  • b cell lymphocytosis (1)
  • BCL-2 (2)
  • BCR Signal Inhibitor (8)
  • bendamustine (2)
  • birc3 (2)
  • Brentuximab (3)
  • BTK (8)
  • CAL-101 / GS-1101 (5)
  • CAR T-cells (3)
  • cd20 (5)
  • clinical trials (1)
  • CLL biology (15)
  • cll prognosis (4)
  • CLL treatment (15)
  • clonal evolution (3)
  • cure (1)
  • diffuse large B cell lymphoma (9)
  • drug costs (9)
  • drug prices (1)
  • dying (3)
  • entospletinib (1)
  • fcr (5)
  • FDA (2)
  • FISH (8)
  • follicular lymphoma (13)
  • generic drugs (1)
  • health care reform (7)
  • holistic care (1)
  • hospice (3)
  • ibrutinib (18)
  • idelalisib (5)
  • immunotherapy (1)
  • lenalidamide (1)
  • lenalidomide (2)
  • lymphoma biology (3)
  • lymphoma treatment (10)
  • mantle cell lymphoma (1)
  • myc (1)
  • notch (4)
  • obinutuzumab (7)
  • ofatumumab (2)
  • off label drugs (2)
  • p53 (5)
  • personalized medicine (5)
  • PI3K (4)
  • R-CHOP (2)
  • Research Drugs (13)
  • rituximab (6)
  • scans (1)
  • sf3b1 (1)
  • stereotype (1)
  • supplements (1)
  • syk (1)
  • T cell therapy (3)
  • transplant (2)
  • trisomy 12 (1)
  • venetoclax (1)
  • videos (7)
  • watch and wait (2)
  • zydelig (1)

Popular Posts

  • 17p Deletion in CLL
    17p is the genomic alteration in CLL that triggers the greatest concern in most patients.  It can have a tremendous impact on CLL prognosi...
  • When to treat CLL
    The " watch and wait " mantra in CLL can be a test of wills unlike most other cancer experiences. Let's face it, sitting the...
  • Mutated vs. Unmutated CLL
    I was surprised to realize that I have not posted on the difference between “mutated” and “unmutated” CLL.   This is such a basic charac...
  • CLL Prognosis
    Many CLL patients identify themselves by their prognostic markers when writing in social media outlets.  "Diagnosis age 63, unmutated, ...
  • Monoclonal B Cell Lymphocytosis
    If you took blood samples from individuals on an annual basis and stuck them in the freezer for analysis sometime later, you would find that...
  • FCR: The Empire Strikes Back
    I'm not really a huge Star Wars guy, but the title seemed appropriate for the content.  For web savvy CLL patients FCR is a lot like the...
  • The Slow (Indolent) Lymphomas
    In my prior post " Understanding The Different Types of Lymphoma " I spent a bit of time explaining how there were three main cate...

Blog Archive

  • ▼  2017 (2)
    • ▼  April (1)
      • Research Plug!
    • ►  February (1)
  • ►  2016 (4)
    • ►  May (1)
    • ►  April (2)
    • ►  March (1)
  • ►  2015 (5)
    • ►  November (1)
    • ►  June (1)
    • ►  May (1)
    • ►  February (2)
  • ►  2014 (22)
    • ►  November (1)
    • ►  October (1)
    • ►  September (6)
    • ►  July (3)
    • ►  June (1)
    • ►  May (2)
    • ►  April (1)
    • ►  March (1)
    • ►  February (3)
    • ►  January (3)
  • ►  2013 (50)
    • ►  December (4)
    • ►  November (8)
    • ►  October (2)
    • ►  September (3)
    • ►  July (2)
    • ►  June (7)
    • ►  May (11)
    • ►  April (5)
    • ►  March (2)
    • ►  February (1)
    • ►  January (5)
  • ►  2012 (30)
    • ►  December (4)
    • ►  November (2)
    • ►  October (4)
    • ►  September (5)
    • ►  August (8)
    • ►  July (7)

Good Discussion Groups

  • Lymphomation
  • Lymphoma Forum
  • CLL Forum
  • Yahoo Group CLL/SLL
  • Gotcll
  • CLL Topics
  • CLL Canada

Educational Links

  • LLS CLL Book
  • LLS Lymphoma book
  • Good European Perspective on CLL
  • Genentech Follicular Lymphoma Page
  • Genentech DLBCL page
  • Genentech CLL Page

Subscribe To

Posts
Atom
Posts
All Comments
Atom
All Comments

Follow this blog

Posts
Atom
Posts
All Comments
Atom
All Comments

RSS feed

Posts
Atom
Posts
All Comments
Atom
All Comments
Powered by Blogger.